FIELD: medicine.
SUBSTANCE: invention relates to field of medicine and represents coating for medical device, inhibiting aggressive form of healing, which contains, at least, one nitrocarboxylic acid.
EFFECT: invention ensures provision of coatings for medical devices, which possess advantages with respect to stability, adhesion of cells, growth of cells, biocontamination, biocompatibility and bioresistance.
5 cl, 7 dwg, 1 tbl, 19 ex
| Title | Year | Author | Number |
|---|---|---|---|
| DEVICE AND METHOD FOR SOLUBILISING, SEPARATING, REMOVING AND REACTING CARBOXYLIC ACIDS IN OILS, FATS, AQUEOUS OR ORGANIC SOLUTIONS BY MEANS OF MICRO- OR NANOEMULSIFICATION | 2011 |
|
RU2581368C2 |
| CARBOHYDRATE-GLYCOLIPID CONJUGATE VACCINES | 2013 |
|
RU2649009C2 |
| MEDICAL DEVICE FOR TREATING LUMEN OBTURATIONS AND PREVENTING THREATENING RECURRENT OBTURATIONS | 2008 |
|
RU2458710C2 |
| PHARMACEUTICALLY ACTIVE COMPOUNDS AS Axl INHIBITORS | 2011 |
|
RU2573834C2 |
| ENDOPROSTHESIS, COATED WITH ACTIVE COMPOUND | 2012 |
|
RU2592367C2 |
| CATHETER CYLINDER | 2011 |
|
RU2633723C2 |
| PYRIDINONE DERIVATIVES AS TISSUE TRANSGLUTAMINASE INHIBITORS | 2013 |
|
RU2652987C2 |
| COMPOUNDS EXHIBITING SELECTIVITY WITH RESPECT TO RETINOID RECEPTORS, PHARMACEUTICAL COMPOSITION (VARIANTS), METHOD OF MODULATION OF PROCESSES (VARIANTS), METHOD OF SUPPRESSION OF PATHOLOGICAL STATES | 1993 |
|
RU2144913C1 |
| STENT | 2007 |
|
RU2432183C9 |
| MONOESTER COMPOUNDS, PHARMACEUTICAL COMPOSITION | 1994 |
|
RU2139884C1 |
